Publication | Closed Access
Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib/Proteasome inhibitor PS-341
59
Citations
25
References
2004
Year
Hematological MalignancyAnti-myeloma ActivityBortezomib/proteasome Inhibitor Ps-341MedicineImmunologyUbiquitin-conjugating Enzyme Cdc34Anti-cancer AgentRadiation OncologyOncologyCell BiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1